NKRF

NKRF (NF-κB repressing factor) is a predominantly nucleolar protein that acts as a constitutive transcriptional repressor of NF-κB target genes, restraining basal inflammatory gene expression (PMID:15226370). It silences the IFN-β, IL-8, and iNOS genes by binding cis-acting negative regulatory elements (NRE) in their promoters, mediating constitutive but not stimulus-induced repression (PMID:15226370). Paradoxically, NKRF also physically engages NF-κB p65 — an interaction mapped to NKRF residues 223–238 — and disruption of this contact reduces, rather than increases, IL-8 transcription in IL-1-stimulated and Helicobacter pylori-infected epithelial cells, indicating that NKRF/p65 association is required for IL-8 gene activation in those contexts (PMID:18025206). NKRF localizes to nucleoli through a large central domain whose retention depends on double-stranded RNA binding, as actinomycin D treatment releases it from the nucleolus (PMID:15226370). Its own expression is controlled at multiple post-transcriptional levels: NKRF mRNA is translated via a 5'-UTR IRES whose activity depends on the RNA-binding protein JKTBP1 (PMID:17592041), the mRNA is stabilized by HuR through AU-rich elements (PMID:33330514), and it is repressed by miR-301a/miR-301a-3p and miR-192, which downregulate NKRF to license NF-κB nuclear translocation and inflammatory or pro-survival signaling (PMID:31527198, PMID:34953057, PMID:32468020). Through this repressive output, NKRF restrains pathological NF-κB-driven processes in vivo, including ventilator-induced lung injury (PMID:23840526), intervertebral disc degeneration (PMID:33330514), JEV-associated neuroinflammation (PMID:31527198), and post-myocardial-infarction cardiac remodeling, where cardiac-fibroblast NKRF suppresses HuR transcription via NRE binding to limit MMP2/MMP9-driven invasion (PMID:37667861).

1. 2004 High

   Established where NKRF resides and how it is retained there, linking its localization to RNA binding rather than canonical protein-targeting alone.

   Evidence GFP tagging, confocal microscopy, FRAP, deletion mapping, and dsRNA-binding/actinomycin D assays

   PMID:15226370

   Open questions at the time

   • The functional consequence of nucleolar sequestration for transcriptional repression is not defined
   • The dsRNA ligand(s) retained in the nucleolus are not identified
2. 2004 Medium

   Defined NKRF's core function as a constitutive repressor acting through promoter NRE elements, distinguishing basal silencing from inducible expression.

   Evidence mRNA ablation knockdown with promoter-binding readouts on IFN-β, IL-8, and iNOS

   PMID:15226370

   Open questions at the time

   • The corepressor machinery NKRF recruits at NREs is not identified
   • Why repression is constitutive but lost upon stimulation is unexplained
3. 2007 High

   Mapped a direct NKRF/NF-κB p65 interaction interface and showed, unexpectedly, that this contact is required for IL-8 activation, complicating the simple repressor model.

   Evidence Tandem affinity purification plus a 223–238 peptide inhibitor nucleofected into IL-1-stimulated and H. pylori-infected epithelial cells

   PMID:18025206

   Open questions at the time

   • The reconciliation between NRE-mediated repression and p65-dependent activation at the same locus is unresolved
   • Structural basis of the 223–238 contact with p65 is unknown
4. 2007 High

   Showed NKRF protein output is set translationally through an IRES, identifying JKTBP1 as a trans-acting factor controlling NKRF abundance.

   Evidence RNA structure probing, mutagenesis, dicistronic reporters, mass spectrometry, EMSA, and JKTBP1 siRNA knockdown

   PMID:17592041

   Open questions at the time

   • Conditions that favor cap-independent over cap-dependent NKRF translation are not defined
   • Whether IRES usage changes during inflammation is untested
5. 2013 Medium

   Placed NKRF pathway activation as a contributor to mechanical-stress lung injury in vivo.

   Evidence Mouse ventilator-induced lung injury model with NKRF siRNA and iPSC/conditioned-medium rescue

   PMID:23840526

   Open questions at the time

   • The molecular events downstream of NKRF activation in this model are not dissected
   • Whether NKRF acts here as repressor or via p65 association is unclear
6. 2019 High

   Established NKRF as a direct miRNA target whose loss de-represses NF-κB, with reciprocal rescue confirming pathway placement in neuroinflammation.

   Evidence miR-301a gain/loss-of-function with NKRF rescue in microglia and in vivo miR-301a neutralization in mouse brain

   PMID:31527198

   Open questions at the time

   • Direct 3'UTR binding site not mapped in this study
   • Upstream signals controlling miR-301a are not defined
7. 2020 High

   Identified HuR-dependent mRNA stabilization as a positive post-transcriptional control of NKRF, with disease relevance in disc degeneration.

   Evidence HuR overexpression/knockdown, mRNA stability assays, NKRF rescue, and a rat IVDD model

   PMID:33330514

   Open questions at the time

   • The interplay between HuR stabilization and miRNA repression of NKRF is not integrated
   • AU-rich element location within NKRF mRNA not precisely mapped here
8. 2020 Medium

   Extended the miRNA→NKRF→NF-κB axis to cancer, showing direct 3'UTR targeting drives proliferation and invasion.

   Evidence miR-301a-3p overexpression with luciferase 3'UTR reporter and proliferation/invasion assays in gastric cancer cells

   PMID:32468020

   Open questions at the time

   • Single-lab functional readout without in vivo confirmation
   • Endogenous miR-301a-3p levels in patient tissue not correlated with NKRF
9. 2021 Medium

   Showed a second miRNA (miR-192) suppresses NKRF to drive NF-κB-dependent anti-apoptotic gene expression and chemoresistance.

   Evidence miR-192 manipulation, 3'UTR luciferase reporter, and cisplatin-resistance assays with NF-κB inhibitor rescue in lung cancer cells

   PMID:34953057

   Open questions at the time

   • No in vivo validation of the miR-192/NKRF axis
   • Whether multiple miRNAs co-regulate NKRF in the same tumor is untested
10. 2023 High

    Defined a concrete physiological repressor circuit: NKRF binds the HuR promoter NRE to limit MMP2/MMP9 and protect against cardiac remodeling, using a conditional knockout.

    Evidence Cardiac-fibroblast-specific NKRF knockout mice, promoter NRE mutagenesis, migration/invasion assays, and post-MI echocardiography

    PMID:37667861

    Open questions at the time

    • The NF-κB-dependent component of NKRF binding at the HuR promoter is not mechanistically separated from direct NRE binding
    • Generality of the NKRF→HuR repression to other cell types is unknown
11. 2017 Medium

    Showed the invertebrate NKRF ortholog interacts with NF-κB family members but enhances rather than inhibits NF-κB, revealing context- or species-dependent directionality.

    Evidence LvNKRF identification, interaction assays with Dorsal and Relish, and RNAi during WSSV infection in shrimp

    PMID:28564581

    Open questions at the time

    • Whether the opposite functional sign reflects a species difference or assay context is unresolved
    • Direct relevance to mammalian NKRF mechanism is limited

• It remains unresolved how NKRF switches between repressing NF-κB targets via NRE binding and being required for p65-dependent activation, and what corepressor/coactivator machinery and nucleolar RNA functions underlie these opposing outputs.
• No structural model of the NKRF–NRE or NKRF–p65 complexes
• The corepressor complex recruited at NREs is unidentified
• Functional role of nucleolar dsRNA-dependent retention in transcriptional control is unknown